Cargando…
Renal tubular damage and clinical outcome in heart failure with preserved ejection fraction and chronic kidney disease
AIMS: Despite advances in heart failure (HF) treatment, HF with preserved ejection fraction (HFpEF) remains a health problem with a high mortality rate. HFpEF is composed of diverse phenogroups, of which patients with concomitant renal impairment have worse outcomes. Renal tubular damage (RTD) is as...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375165/ https://www.ncbi.nlm.nih.gov/pubmed/37264723 http://dx.doi.org/10.1002/ehf2.14378 |
_version_ | 1785078976388005888 |
---|---|
author | Otaki, Yoichiro Watanabe, Tetsu Shimizu, Mari Tachibana, Shingo Sato, Junya Kobayashi, Yuta Saito, Yuji Aono, Tomonori Tamura, Harutoshi Kato, Shigehiko Nishiyama, Satoshi Takahashi, Hiroki Arimoto, Takanori Watanabe, Masafumi |
author_facet | Otaki, Yoichiro Watanabe, Tetsu Shimizu, Mari Tachibana, Shingo Sato, Junya Kobayashi, Yuta Saito, Yuji Aono, Tomonori Tamura, Harutoshi Kato, Shigehiko Nishiyama, Satoshi Takahashi, Hiroki Arimoto, Takanori Watanabe, Masafumi |
author_sort | Otaki, Yoichiro |
collection | PubMed |
description | AIMS: Despite advances in heart failure (HF) treatment, HF with preserved ejection fraction (HFpEF) remains a health problem with a high mortality rate. HFpEF is composed of diverse phenogroups, of which patients with concomitant renal impairment have worse outcomes. Renal tubular damage (RTD) is associated with the development of HF and chronic kidney disease (CKD). However, the impact of RTD on HF progression in patients with HFpEF and CKD remains unclear. The aim of the present study was to examine whether RTD could predict HF‐related events in patients with HFpEF and CKD. METHODS AND RESULTS: We measured RTD markers, such as urinary β(2)‐microglobulin to creatinine ratio (UBCR) and N‐acetyl‐β‐d‐glucosamidase (NAG) level, in 319 consecutive patients with HFpEF and CKD who were hospitalized for acute HF (49% females, mean age 76 ± 12). Based on previous reports, high UBCR and high NAG levels were defined as UBCR ≥300 μg/gCr and NAG >14.2 U/gCr, respectively. There were 91 HF‐related events, defined as HF hospitalizations or HF deaths, during the median follow‐up period of 5.2 years. The prevalence of high UBCR increased with advancing New York Heart Association functional class and albuminuria. Kaplan–Meier analysis demonstrated that patients with high UBCR had more HF‐related events than those with normal or low UBCR. Multivariate Cox proportional hazards regression analyses demonstrated that high UBCR, but not high NAG level, was an independent predictor of HF‐related events after adjusting for confounding risk factors in patients with HFpEF and CKD (hazard ratio, 2.60; 95% confidence interval, 1.52–4.72; P = 0.0009). UBCR significantly improved the C‐statistic, with a significant net reclassification index and integrated discrimination improvement (0.738 vs. 0.684; P = 0.0244). CONCLUSION: RTD, as assessed by a high UBCR, was associated with the severity and clinical outcomes of HFpEF and CKD, indicating that it could be a feasible marker for HF progression. |
format | Online Article Text |
id | pubmed-10375165 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103751652023-07-29 Renal tubular damage and clinical outcome in heart failure with preserved ejection fraction and chronic kidney disease Otaki, Yoichiro Watanabe, Tetsu Shimizu, Mari Tachibana, Shingo Sato, Junya Kobayashi, Yuta Saito, Yuji Aono, Tomonori Tamura, Harutoshi Kato, Shigehiko Nishiyama, Satoshi Takahashi, Hiroki Arimoto, Takanori Watanabe, Masafumi ESC Heart Fail Original Articles AIMS: Despite advances in heart failure (HF) treatment, HF with preserved ejection fraction (HFpEF) remains a health problem with a high mortality rate. HFpEF is composed of diverse phenogroups, of which patients with concomitant renal impairment have worse outcomes. Renal tubular damage (RTD) is associated with the development of HF and chronic kidney disease (CKD). However, the impact of RTD on HF progression in patients with HFpEF and CKD remains unclear. The aim of the present study was to examine whether RTD could predict HF‐related events in patients with HFpEF and CKD. METHODS AND RESULTS: We measured RTD markers, such as urinary β(2)‐microglobulin to creatinine ratio (UBCR) and N‐acetyl‐β‐d‐glucosamidase (NAG) level, in 319 consecutive patients with HFpEF and CKD who were hospitalized for acute HF (49% females, mean age 76 ± 12). Based on previous reports, high UBCR and high NAG levels were defined as UBCR ≥300 μg/gCr and NAG >14.2 U/gCr, respectively. There were 91 HF‐related events, defined as HF hospitalizations or HF deaths, during the median follow‐up period of 5.2 years. The prevalence of high UBCR increased with advancing New York Heart Association functional class and albuminuria. Kaplan–Meier analysis demonstrated that patients with high UBCR had more HF‐related events than those with normal or low UBCR. Multivariate Cox proportional hazards regression analyses demonstrated that high UBCR, but not high NAG level, was an independent predictor of HF‐related events after adjusting for confounding risk factors in patients with HFpEF and CKD (hazard ratio, 2.60; 95% confidence interval, 1.52–4.72; P = 0.0009). UBCR significantly improved the C‐statistic, with a significant net reclassification index and integrated discrimination improvement (0.738 vs. 0.684; P = 0.0244). CONCLUSION: RTD, as assessed by a high UBCR, was associated with the severity and clinical outcomes of HFpEF and CKD, indicating that it could be a feasible marker for HF progression. John Wiley and Sons Inc. 2023-06-01 /pmc/articles/PMC10375165/ /pubmed/37264723 http://dx.doi.org/10.1002/ehf2.14378 Text en © 2023 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Otaki, Yoichiro Watanabe, Tetsu Shimizu, Mari Tachibana, Shingo Sato, Junya Kobayashi, Yuta Saito, Yuji Aono, Tomonori Tamura, Harutoshi Kato, Shigehiko Nishiyama, Satoshi Takahashi, Hiroki Arimoto, Takanori Watanabe, Masafumi Renal tubular damage and clinical outcome in heart failure with preserved ejection fraction and chronic kidney disease |
title | Renal tubular damage and clinical outcome in heart failure with preserved ejection fraction and chronic kidney disease |
title_full | Renal tubular damage and clinical outcome in heart failure with preserved ejection fraction and chronic kidney disease |
title_fullStr | Renal tubular damage and clinical outcome in heart failure with preserved ejection fraction and chronic kidney disease |
title_full_unstemmed | Renal tubular damage and clinical outcome in heart failure with preserved ejection fraction and chronic kidney disease |
title_short | Renal tubular damage and clinical outcome in heart failure with preserved ejection fraction and chronic kidney disease |
title_sort | renal tubular damage and clinical outcome in heart failure with preserved ejection fraction and chronic kidney disease |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375165/ https://www.ncbi.nlm.nih.gov/pubmed/37264723 http://dx.doi.org/10.1002/ehf2.14378 |
work_keys_str_mv | AT otakiyoichiro renaltubulardamageandclinicaloutcomeinheartfailurewithpreservedejectionfractionandchronickidneydisease AT watanabetetsu renaltubulardamageandclinicaloutcomeinheartfailurewithpreservedejectionfractionandchronickidneydisease AT shimizumari renaltubulardamageandclinicaloutcomeinheartfailurewithpreservedejectionfractionandchronickidneydisease AT tachibanashingo renaltubulardamageandclinicaloutcomeinheartfailurewithpreservedejectionfractionandchronickidneydisease AT satojunya renaltubulardamageandclinicaloutcomeinheartfailurewithpreservedejectionfractionandchronickidneydisease AT kobayashiyuta renaltubulardamageandclinicaloutcomeinheartfailurewithpreservedejectionfractionandchronickidneydisease AT saitoyuji renaltubulardamageandclinicaloutcomeinheartfailurewithpreservedejectionfractionandchronickidneydisease AT aonotomonori renaltubulardamageandclinicaloutcomeinheartfailurewithpreservedejectionfractionandchronickidneydisease AT tamuraharutoshi renaltubulardamageandclinicaloutcomeinheartfailurewithpreservedejectionfractionandchronickidneydisease AT katoshigehiko renaltubulardamageandclinicaloutcomeinheartfailurewithpreservedejectionfractionandchronickidneydisease AT nishiyamasatoshi renaltubulardamageandclinicaloutcomeinheartfailurewithpreservedejectionfractionandchronickidneydisease AT takahashihiroki renaltubulardamageandclinicaloutcomeinheartfailurewithpreservedejectionfractionandchronickidneydisease AT arimototakanori renaltubulardamageandclinicaloutcomeinheartfailurewithpreservedejectionfractionandchronickidneydisease AT watanabemasafumi renaltubulardamageandclinicaloutcomeinheartfailurewithpreservedejectionfractionandchronickidneydisease |